Company Filing History:
Years Active: 2003-2014
Title: The Innovative Contributions of Thorsten A. Kirschberg
Introduction
Thorsten A. Kirschberg is a prominent inventor based in Mountain View, California. He has made significant contributions to the field of drug delivery systems, holding a total of eight patents. His work focuses on enhancing the delivery of drugs across various biological barriers, which has important implications for medical treatments.
Latest Patents
Among his latest patents, one notable invention is titled "Compositions and methods for enhancing drug delivery across and into ocular tissues." This invention provides compositions and methods that improve the delivery of drugs and other agents across epithelial tissues, particularly ocular tissues. The methods utilize a delivery-enhancing transporter with guanidino or amidino sidechain moieties, which significantly improves the delivery of conjugated compounds compared to their non-conjugated counterparts. Another significant patent is "Compositions and methods for enhancing drug delivery across and into epithelial tissues." This invention similarly enhances drug delivery across various epithelial tissues, including the skin and gastrointestinal tract, employing similar delivery-enhancing polymers.
Career Highlights
Throughout his career, Thorsten has worked with notable companies such as Cellgate, Inc. and Kai Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug delivery.
Collaborations
Thorsten has collaborated with esteemed colleagues, including Jonathan B. Rothbard and Paul A. Wender. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Thorsten A. Kirschberg's innovative work in drug delivery systems has the potential to transform medical treatments and improve patient outcomes. His contributions to the field are marked by a commitment to enhancing the efficacy of drug delivery across critical biological barriers.